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Chemical Stability of 𝜶-Tocopherol in Colloidal Lipid
Particles with Various Morphologies
Anja Schröder,* Joris Sprakel, Karin Schroën, and Claire C. Berton-Carabin
Colloidal lipid particles (CLPs) are promising encapsulation systems for
lipophilic bioactives, such as oil-soluble antioxidants that are applied in food
and pharmaceutical formulations. Currently, there is no clear consensus
regarding the relation between particle structure and the chemical stability of
such bioactives. Using 𝜶-tocopherol as a model antioxidant, it is shown that
emulsifier type (Tween 20 or 40, or sodium caseinate) and lipid composition
(tripalmitin, tricaprylin, or combinations thereof ) modulated particle
morphology and antioxidant stability. The emulsifier affects particle shape,
with the polysorbates facilitating tripalmitin crystallization into highly ordered
lath-like particles, and sodium caseinate resulting in less ordered spherical
particles. The fastest degradation of 𝜶-tocopherol is observed in
tripalmitin-based CLPs, which may be attributed to its expulsion to the
particle surface induced by lipid crystallization. This effect is stronger in CLPs
stabilized by Tween 40, which may act as a template for crystallization. This
work not only shows how the architecture of CLPs can be controlled through
the type of lipid and emulsifier used, but also gives evidence that lipid
crystallization does not necessarily protect entrapped lipophilic bioactives,
which is an important clue for encapsulation system design.
Practical Applications: Interest in enriching food and pharmaceutical products
with lipophilic bioactives such as antioxidants through encapsulation in lipid
particles is growing rapidly. This research suggests that for efficient
encapsulation, the particle architecture plays an important role; to tailor this,
the contribution of both the lipid carrier and the emulsifier needs to be
considered.
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1. Introduction
The interest in enriching food and pharma-
ceutical products with lipophilic bioactives
(for example, vitamins, flavors, pigments,
antioxidants) is growing rapidly, and of-
ten involves encapsulation to protect these
bioactives against chemical degradation, to
enhance their solubility, activity, or absorp-
tion, and to control their delivery.[1–3] Sub-
micron and partly solid lipid droplets that
may be referred to as colloidal lipid particles
(CLPs) have emerged as potential encapsu-
lation systems for lipophilic bioactive com-
pounds, and have been extensively studied
lately.[4–9]
It may be useful to clarify the related ter-
minology: the term “solid lipid nanoparti-
cle” (SLN) has been extensively used, but is
not always appropriate, because i) the lipid
phase may not be fully solid, and ii) the
prefix “nano” applies to “natural, incidental
or manufactured material containing parti-
cles, in an unbound state or as an aggregate
or as an agglomerate of which, for 50% or
more of the particles in the number size dis-
tribution, one or more external dimensions
is between 1–100 nm” (Bleeker et al.[10]).
This classification does not hold for all parti-
cles termed SLNs (Bleeker et al.,[10,11]). This
is why “solid lipid particle” (SLP) should be
preferred[12]; or, if the lipid phase is not fully crystallized,
“(nano)structured lipid carrier” may be more accurate,[13] or “col-
loidal lipid particle”, which is more generic, and will be used in
the present work.
CLP dispersions can be manufactured easily at large-scale
using high pressure homogenization, which also allows el-
evated temperatures when using high melting point (HMP)
fats.[14] Biocompatible lipids can be used to make a lipid ma-
trix with minimal toxicity, and relatively high encapsulation ef-
ficiency for lipophilic components compared to, for example,
liposomes.[3,15–17] Lipid materials that are partly or fully crystal-
lized have been suggested to protect labile lipophilic molecules
against chemical degradation (often, oxidation) by preventing
accumulation at the interface[11,18,19] and by limiting diffusion
of molecules involved in the oxidative reaction throughout the
lipid phase.[12] A solid lipid matrix has also been suggested
to increase control over bioactive release, for example, under
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digestive conditions,[12,13,20] to improve absorption into the lymph
and blood,[21,22] and to delay lipid digestion.[12]
The design of CLPs entrapping a lipophilic bioactive brings
along challenges since the functionality depends on the lipid ma-
trix structure.[23] Lipidswith a sufficiently highmelting pointmay
crystallize directly after CLP preparation in a polymorphic form
that will depend on the lipid purity, presence of other ingredients
(in particular, emulsifiers), and cooling rate. CLPs may also re-
crystallize during storage into more stable polymorphic forms.
Lipids with a high purity can form highly ordered crystalline
structures, which can result in the expulsion of the encapsulated
lipophilic compound from the crystalline matrix.[19] This is espe-
cially the case when CLPs are manufactured with HMP alkanes
or triacylglycerols with a narrow melting range.[2,24,25] This may
lead to enhanced chemical degradation of the encapsulated com-
pound by aqueous phase reactants,[25,26] although in some appli-
cations slow release (i.e., a certain degree of expulsion) may be
desirable, for example, when the activity of an antioxidant should
be maintained for prolonged periods.[5]
To counteract such an often undesirable expulsion and to
increase the lipophilic compound-loading capacity, the use of
blended lipids has been proposed.[13,20] This leads to a lipid phase
with a broader melting range compared to a pure lipid, resulting
in a more disordered crystalline structure that is less prone to
polymorphic transitions.[2] Alternatively, fat crystallization can be
influenced by the molecular structure of emulsifier used to stabi-
lize the CLPs.[6,18,27] For instance, surfactants with a highmelting
point alkyl chain can induce surface-templated crystallization
of the lipid phase, promoting crystal growth from the interface
therewith initiating particle structure and morphology,[28–30]
which promoted the stability of labile lipophilic
molecules.[3,29]
We selected 𝛼-tocopherol (vitamin E), as model lipophilic
bioactive to be encapsulated in CLPs. Being a naturally occurring
chain-breaking antioxidant, it is relevant to a broad range of food
and biobased applications, and poses challenges due to its chem-
ical instability and poor solubility in water.[5,7,31,32] A few studies
have attempted at encapsulating 𝛼-tocopherol in related systems;
Dingler et al.[33] showed that SLNs protected it better against
chemical degradation than an oil-in-water emulsion.[33] Oehlke
et al.[5] found that tocopherol-containing SLNs had good physical
stability and showed a gradual release of tocopherol, which is
important for systems in which long term radical scavenging
activity is desired.[5] For oil-in-water emulsions, it was found
that up to 95% of tocopherol was located in the emulsifier layer
rather than the core of the droplets.[34] Although these findings
are very relevant, general guidelines that link the choice of lipids
and emulsifiers to CLP structure, and to bioactive stability, are
not available yet.
In the present work, we therefore systematically investi-
gated the effect of lipid (tripalmitin, tricaprylin, or combina-
tions thereof) and emulsifier (Tween 20 or Tween 40, i.e., surfac-
tants with alkyl chains of low or high melting point, respectively;
or sodium caseinate, i.e., a disordered protein) on CLP mor-
phology, crystalline structure, and the stability of 𝛼-tocopherol.
Understanding these aspects, and how they are linked, can
be used as the starting point for the rational design of CLPs




Tripalmitin (#T8127, purity > 99%), tricaprylin (#91 040, purity
> 99.6%), Tween 20 (#P1379), Tween 40 (#P1504), sodium
phosphate monobasic (#S9638), sodium phosphate dibasic
(#S9763), sodium chloride (#S9888, purity 99%), iron(II) sul-
fate heptahydrate (#F8633), ethylenediaminetetraacetic acid
disodium salt dihydrate (#E6635), and 𝛼-tocopherol (#T3251)
were purchased from Sigma-Aldrich (Saint Louis, USA).
Methanol (#813 012 802), chloroform (#803 010 802), and hex-
ane (#808 023 502) were obtained from Actu-All Chemicals (Oss,
the Netherlands). Sodium caseinate (#41 610, spray dried, pro-
tein content 91.0%) was supplied by DMV International (Veghel,
the Netherlands). Ultrapure water (18 MΩ) was prepared using a
Milli-Q system (Millipore Corporation, Billerica, MA, USA) and
was used for all the experiments. All other chemicals used were
of analytical grade. The chemicals were used without further
purification.
2.2. Methods
2.2.1. Preparation of Colloidal Lipid Particles (CLPs)
An aqueous phase (95% w/w) containing 1% w/w sodium ca-
seinate or 2% w/w Tween 20 or 40 in phosphate buffer (10 mm,
pH 7.0) was heated to 80 °C in a water bath and added it to
a melted fat phase (5% w/w) (tripalmitin, tricaprylin, or tri-
palmitin mixed with tricaprylin in a mass ratio 4:1) preheated
at the same temperature, which had previously been spiked with
100 µL methanolic solution of 𝛼-tocopherol (200 mg mL−1). Fi-
nal 𝛼-tocopherol concentration was 4 mg g−1 of fat. A coarse
emulsion was prepared by high speed stirring the mixture at
11 000 rpm for 1 min using a preheated rotor-stator homoge-
nizer (Ultra-turrax IKA T18 basic, Germany). We then homog-
enized this coarse emulsion using a high pressure homogenizer
(Microfluidizer Processor MF 110Y equipped with a Y-shaped in-
teraction chamber (F12Y; minimum internal dimension: 75 µm);
Microfluidics, Newton, Massachusetts, USA) at 800 bar (five cy-
cles) and 80 °C to obtain submicron-sized droplets, which were
left to cool at refrigerated temperature (4 °C) over ≈2 h, inducing
crystallization, except for the CLPs made with pure tricaprylin as
the oil phase, which were fully liquid at the temperatures used in
this work.
2.2.2. Characterization of CLPs
The particle size distribution and average diameters (d3,2) were
determined by static light scattering (Malvern Mastersizer 3000,
Malvern Instruments Ltd., Malvern, Worcestershire, UK). The
following optical properties were used: refractive indices of
1.540 (lipid phase) and 1.330 (water) with an absorption index of
0.01. Particle size distributions of CLPs after 14 days incubation
under oxidative conditions are reported in Figure S1, Supporting
Information.
Particle surface charge was evaluated by 𝜁 -potential measured
with a dynamic light scattering instrument (Zetasizer Nano ZS,
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Malvern Instruments,UK) at 25 °C. Emulsionswere diluted≈500
times in phosphate buffer (10 mm, pH 7.0) to prevent multiple
scattering.
Transmission electron microscopy (TEM) was performed on
CLPs (dispersions were diluted ≈100-fold) deposited onto a
freshly glow discharged carbonized copper grid (200 mesh). The
excess solvent was blotted using standard filter paper. The parti-
cles were stained with a 1% w/w phosphotungstic acid solution
(PTA). Images were recorded on a JEOL JEM 1400 plus transmis-
sion electron microscope (Peabody, USA) operating at 120 kV in
combination with a JEOL CCD camera Ruby (8 m pixel).
The melting and crystallization behavior of CLPs was inves-
tigated using a differential scanning calorimeter (Discovery Se-
ries DSC 250, TA Instruments, Zellik, Belgium). CLP dispersion
(≈25 mg) was placed in a T zero pan closed with a hermetic lid,
and was heated from −10 to 80 °C at 1 °C min−1, then cooled
down to −10 °C at 1°C min−1 followed by two identical heat-
ing/cooling cycles. An empty pan was used as a reference. The
thermograms were evaluated using the TRIOS software; melting
and crystallization enthalpies are reported in Table S2, Support-
ing Information.
2.2.3. Incubation of CLP Dispersions
An oxidation initiator system consisting of an equimolar mix-
ture of FeSO4 and EDTA was prepared by mixing equivalent
volumes of separately dissolved FeSO4 and EDTA (8.4 mm) in
phosphate buffer under moderate stirring in the dark for one
hour.[35] Aliquots of CLP dispersion (2 g) were distributed in
15-mL polypropylene centrifuge tubes, and the oxidation initia-
tor solution (100 µL) was added to obtain a final concentration
of 200 µm of both iron and EDTA. The tubes were rotated in the
dark at 2 rpm at 25 °C for 72 h (SB3 rotator, Stuart, Staffordshire,
UK).
2.2.4. Extraction of 𝛼-Tocopherol
𝛼-Tocopherol was extracted from the CLPs by adding 4 mL of
chloroform, 3 mL of methanol, and 1 mL of saturated sodium
chloride solution to 2 mL CLP dispersion in a 15-mL polypropy-
lene centrifuge tube, which was vortexed followed by centrifuga-
tion at 2000 × g for 8 min. The clear chloroform phase was then
collected by cautiously boring a hole in the bottom of the cen-
trifugation tube.
2.2.5. Quantification of 𝛼-Tocopherol by HPLC Analysis
The obtained extracts were analyzed on a UltiMate 3000 liq-
uid chromatography system (Thermo Scientific, Sunnyvale, CA,
USA) using a carotenoid C30 reversed phase column, 3 µm,
150 mm × 4.6 mm (YMC, Dinslaken, Germany). Extracts were
eluted at 1 mL min−1 at 30 °C using a mobile phase with a lin-
ear gradient going from 81%methanol, 14%methyl t-butyl ether
(MTBE), and 4% ultrapure water to 74%methanol, 22%methyl t-
butyl ether, and 4% ultrapure water within 8min, and going back
to its initial composition in 2 min. 𝛼-Tocopherol was detected
with a UV–vis detector at 292 nm (Dionex UltiMate 3000 Vari-
able Wavelength Detector), and contents were calculated using
a calibration curve that was linear in the range from 5 µg mL−1
to 5000 µg mL−1. When studying the chemical degradation of
𝛼-tocopherol during incubation of CLP dispersions, the results
were expressed as normalized 𝛼-tocopherol amount (%), taking
as a reference the 𝛼-tocopherol concentration in the respective
CLP suspension just after production.
2.2.6. Experimental Design
All CLPs were prepared and characterized as at least independent
duplicates. Size and 𝜁 -potential measurements were performed
in triplicate, and extractions and HPLC analyses were performed
in duplicate. All results are reported as the mean and standard
deviation of all measurements.
3. Results and Discussion
3.1. Physical Characteristics of CLPs
CLPs were produced by high pressure homogenization of an
aqueous phase containing Tween 20, Tween 40, or sodium ca-
seinate with either melted tripalmitin, or tripalmitin mixed with
tricaprylin in a mass ratio 4:1, or tricaprylin, followed by cool-
ing. The particle size distribution of all CLPs just after prepara-
tion was unimodal, with a mean diameter (d3,2) of 90–110 nm for
surfactant-stabilized CLPs, or 120–150 nm for sodium caseinate-
stabilized CLPs (Figure 1A–C). The particle size was thus slightly
dependent on the type of emulsifier, which can be explained
by the fact that surfactants lower the interfacial tension more
compared to proteins, which facilitates droplet break-up during
homogenization.[36] For a given emulsifier, increasing the liquid
fat content slightly decreased the droplet size, which can be at-
tributed to the lower viscosity of these oil phases, which, again,
facilitates droplet break-up.[37] Fat composition also affected the
surface charge of CLPs stabilized by Tween 20 and Tween 40, with
more negative 𝜁 -potential for tripalmitin particles (Figure 1D).
This could be caused by the crystallinity of the fat in the CLPs,
promoting ion binding at the particle surface.[38] CLPs stabilized
by Tween 20 and Tween 40 showed a lower net 𝜁 -potential (−5
to −15 mV) compared to sodium caseinate-stabilized CLPs (−30
to −35 mV): polysorbate surfactants are non-ionic,[39] whereas
sodium caseinate contains ionizable groups and has an isoelec-
tric point around 4.6,[40] making it strongly negatively charged at
neutral pH.
We visualized the CLPs with transmission electron mi-
croscopy, and found clear morphological differences (Figure 2).
Pure tripalmitin-based CLPs stabilized with Tween 20 or Tween
40 had a lath-like morphology with a high aspect ratio. When
they contained a fraction of tricaprylin, more platelet-like parti-
cles with a much lower aspect ratio were obtained. Conversely,
pure tripalmitin-based CLPs stabilized with sodium caseinate
were nearly spherical. When these sodium caseinate-stabilized
CLPs contained a fraction of tricaprylin, their morphology also
showed a low aspect ratio, but were more irregular, compared
to tripalmitin-based ones. The morphological differences of the
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Figure 1. Particle size distributions of A) Tween 20-, B) Tween 40-, and C) sodium caseinate- stabilized CLPs containing tripalmitin (red), tri-
palmitin:tricaprylin 4:1 (blue), or tricaprylin (green), and their D) 𝜁 -potential. On panel D, T20, T40 and NaCas stand for Tween 20, Tween 40, and
sodium caseinate, respectively.
particles may be related to their crystallinemicrostructure, which
was further investigated by differential scanning calorimetry
(Figure 3).
Differential scanning calorimetry (DSC) melting thermo-
grams of all pure tripalmitin-based CLPs showed a sequence
of melting peaks that point to a complex layered structure,
which would melt in multiple identifiable events from the
interface.[30,41,42] The melting thermograms of sodium caseinate-
stabilized CLPs also showed a small exothermic peak that indi-
cates crystal reorganization and recrystallization into a more sta-
ble polymorphic form.[43,44] The cooling thermograms of pure
tripalmitin-based CLPs showed a crystallization onset at about
23, 29, and 32 °C for Tween 20-, Tween 40-, and sodium caseinate-
stabilized CLPs, respectively (Figure 3A,C,E), which was much
lower than for bulk tripalmitin (about 43 °C), indicative of a
strong supercooling effect in all CLPs.[44–46]
The cooling thermograms of Tween 20-stabilized tripalmitin
CLPs showed a main crystallization peak with a small shoulder,
which probably corresponds to a dominant 𝛽-subcell fraction and
a small fraction of 𝛽’-subcell crystals.[3,18,30] Tween 40-stabilized
tripalmitin CLPs showed two distinct crystallization peaks, of
which the main one corresponds to 𝛽-subcell crystals that were
formed in the core of the CLP, and the other one most proba-
bly to 𝛼-subcell crystals that were formed by Tween 40-induced
surfactant-templated crystallization,[8,17,47] as reported for high
melting lecithin-induced crystallization.[3] Tween 40 primarily
contains palmitic acid (C16:0) as alkyl chain, which can align
with alike alkyl chains of tripalmitin at the interface, promot-
ing crystallization at the interface. Conversely, sodium caseinate-
stabilized tripalmitin CLPs showed a single crystallization peak,
indicating that the tripalmitin crystallized into one polymorphic
form, most likely corresponding to 𝛼-subcell crystals.[43]
The melting thermograms of CLPs made with tripalmitin-
tricaprylin blends showed a sequence of melting peaks indicative
of multiple melting events, although these events were less dis-
tinct, and showed lower enthalpies than in pure tripalmitin par-
ticles (Table S2, Supporting Information). Tween 20-stabilized
CLPs showed one crystallization peak most likely corresponding
to 𝛽-subcell crystals, whereas for Tween 40-stabilized CLPs
𝛼-subcell crystallization was found corresponding to surfactant-
templated interfacial crystallization, followed by two overlapping
𝛽’and 𝛽-subcell crystallization peaks. Last, sodium caseinate-
stabilized CLPs showed one main 𝛼-subcell crystallization peak
followed by a small 𝛽’or 𝛽-subcell crystallization peak.[3,18] In gen-
eral, the CLPs made with tripalmitin-tricaprylin blends showed
lower crystallization enthalpy and melting temperatures com-
pared to tripalmitin CLPs, which can be attributed to less ordered
crystals.[29,48]
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Figure 2. TEM images of CLPs made of tripalmitin (left), or tripalmitin/tricaprylin 4:1 w/w blend (right), stabilized by A,B) Tween 20, C,D) Tween 40, or
E,F) sodium caseinate.
3.2. Chemical Stability of 𝜶-Tocopherol
The amounts of 𝛼-tocopherol recovered in the CLPs immedi-
ately after production were between 77.0% and 90.1%, with no
significant differences between the particles (Table S3, Support-
ing Information). These initial losses can be caused by the high
temperature, pressure, and presence of oxygen during homoge-
nization. To further study the chemical stability of 𝛼-tocopherol
upon storage of the CLP suspensions in accelerated ageing con-
ditions, we incubated the samples with 200 µm FeSO4/EDTA
at 25°C, and measured the concentration of 𝛼-tocopherol in
time.
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Figure 3. DSC crystallization and melting thermograms of CLPs made of tripalmitin (left) or tripalmitin/tricaprylin 4:1 w/w blend (right), and stabilized
by A,B) Tween 20, C,D) Tween 40, or E,F) sodium caseinate.
The chemical stability of 𝛼-tocopherol was considerably lower
in tripalmitin-based CLPs than in pure tricaprylin-based ones
(Figure 4). After 14 days storage, pure tripalmitin CLPs showed
remaining amounts of ≈85%, 60%, and 80% when stabilized
by Tween 20, Tween 40, or sodium caseinate, respectively, com-
pared to ≈95% in tricaprylin CLPs. Increasing the fraction of liq-
uid tricaprylin in the CLPs increased the chemical stability of
𝛼-tocopherol when using Tween 40 and sodium caseinate as
emulsifiers, but not when using Tween 20. With regard to the ef-
fect of the emulsifier type, the chemical stability of 𝛼-tocopherol
was the lowest for Tween 40-stabilized CLPs, compared to Tween
20- or sodium caseinate-stabilized CLPs.
We found a high 𝛼-tocopherol stability in tricaprylin CLPs
irrespective of the emulsifier used. Tripalmitin or tricaprylin-
tripalmitin blends resulted in crystallized CLPs with various
morphologies, in which the chemical stability of 𝛼-tocopherol
was lower compared to that in tricaprylin-based CLPs. Although
immobilization of lipophilic bioactives within a solid lipid ma-
trix has sometimes been suggested as protective,[8,49,50] the lo-
cation of the bioactive and the structure of the solid lipid ma-
trix also need to be taken into account.[3,24] For example Berton–
Carabin et al.[26] demonstrated that the location and mobility
of small lipophilic molecules were largely dependent on their
structure and on the physical state of lipids in emulsion sys-
tems, which could substantially affect their chemical stability. For
molecules structurally close to 𝛼-tocopherol, fat crystallization
promoted their localization and immobilization at the interface,
but did not change their chemical reactivity with aqueous phase
reactants.[26]
Physical exclusion of the bioactive compound can take place
during crystallization, resulting in closed compartments loaded
with the compound, which leads to an enhanced chemical sta-
bility when in the core of the droplet.[13,17,19,50] If these com-
partments are close to the particle surface, degradation may be
promoted, since they may come into contact with aqueous pro-
oxidant species,[2,13] and leach out due to partitioning. Jenning &
Gohla[4] hypothesized that bioactives with a melting point lower
than that of the lipids used for encapsulation may be pushed to-
ward the particle surface due to lipid crystallization in the lipid
core prior to the bioactive. This could have been the case in our
Eur. J. Lipid Sci. Technol. 2020, 2000012 © 2020 The Authors. European Journal of Lipid Science and Technology
Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
2000012 (6 of 9)
www.advancedsciencenews.com www.ejlst.com
Figure 4. Chemical stability of 𝛼-tocopherol, expressed as normalized 𝛼-tocopherol amount (%), in CLPs stabilized by A) Tween 20, B) Tween 40, or C)
sodium caseinate (NaCas), and prepared with tripalmitin (TP100, red), tripalmitin:tricaprylin 4:1 blend (TP80, blue), or tricaprylin (TP0, green), during
storage under oxidative conditions.
research, resulting in lower chemical stability of 𝛼-tocopherol in
solid or semi-solid CLPs, compared to liquid ones.
In literature, it was suggested that high melting point surfac-
tants form a shell by surface templating that limits diffusion of
prooxidants or oxygen to the oxidizable components.[17,19] Such
a shell let tripalmitin crystallize in a loosely packed crystal form
(𝛼 or 𝛽’-subcell), in which lipophilic compounds can be encapsu-
lated better than in tightly packed 𝛽-subcell crystals.[8,17,47] There-
fore, it was expected that Tween 40 would limit 𝛼-tocopherol
degradation more compared to Tween 20 or sodium caseinate,
but the opposite was observed. We expect that highly ordered 𝛽-
subcell crystals were formed in the core of Tween 40-stabilized
tripalmitin CLPs, as revealed by DSC, which resulted in needle-
shaped CLPs with a high surface area. 𝛼-Tocopherol molecules
could have been pushed out from the particle core by the growing
crystals, and thus present close to the particle surface, where they
would be prone to chemical degradation by aqueous phase pro-
oxidants.[25] Tween 40-stabilized CLPs with mixed tripalmitin-
tricaprylin contained less 𝛽-subcell crystals compared to pure
tripalmitin-based CLPs, had less surface area, and could con-
tain some liquid lipid patches in the core of the CLP.[32] All
these effects may have kept 𝛼-tocopherol more buried within
the particles, leading to higher chemical stability. Tween 20-
stabilized CLPs contained mostly 𝛽-subcell crystals, which are
expected to induce migration of 𝛼-tocopherol from the core to
the surface of the CLPs, where it would eventually have been
degraded. Compared to Tween 40, less 𝛼-tocopherol could have
been initially present at the interface, leading to slower degra-
dation. Sodium caseinate-stabilized CLPs were able to inhibit
degradation of 𝛼-tocopherol to a larger extent compared to both
surfactant-stabilized CLPs; for the tripalmitin-tricaprylin blend,
the stability was even as good as for tricaprylin. Although sodium
caseinate is known to be a metal chelator that effectively prevent
lipids from oxidation when present in large excess in the aqueous
phase,[35,51] this seems an unlikely explanation for our results,
as only low concentrations of excess proteins were present (<
1 g L−1). More likely, the less ordered crystalline structure com-
pared to Tween 20 and Tween 40CLPs allows for 𝛼-tocopherol im-
mobilization, or its inclusion in liquid patches within the core of
the CLPs. This would lead to slow release of 𝛼-tocopherol, which
is important for products in which antioxidant activity needs to
be maintained for an extended period.
4. Conclusions
In this work, we investigated colloidal lipid particles (CLPs)made
with tripalmitin, tricaprylin, or a blend thereof, as encapsulation
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systems for 𝛼-tocopherol. We showed that emulsifier type and
lipid composition modulate the morphology and crystalline
structure of the particles, which consequently affected the chem-
ical stability of 𝛼-tocopherol. Tween 20 and Tween 40 allowed tri-
palmitin to crystallize in highly ordered structures with lath-like
morphology, from which 𝛼-tocopherol was probably expulsed. In
Tween 40-stabilized CLPs, 𝛼-tocopherol probably accumulated
at the surface of the particles, where it was prone to chemical
degradation by aqueous pro-oxidants. In future work, it would
be interesting to validate this by in situ measurements in parti-
cle dispersions, for example, by front-surface fluorescence spec-
troscopy or by electron spin resonance. Sodium caseinate tri-
palmitin CLPs crystallized in a nearly spherical shape with less
ordered crystalline structure in which the 𝛼-tocopherol stability
was high. When a lipid blend was used, the chemical stability of
𝛼-tocopherol increased in most cases, possibly due to the forma-
tion of liquid patches that would keep the bioactive buried within
the particle core. Tricaprylin CLPs had highest chemical stability
of 𝛼-tocopherol irrespective of the emulsifier used, showing that
lipid crystallization does not necessarily protect lipophilic bioac-
tives. From these results it is clear that for efficient encapsulation
of lipophilic bioactives, the particle architecture plays an impor-
tant role; to tailor this, both the lipid and the emulsifier need to
be considered.
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